Is CVS or ISRG cheaper?

On trailing earnings, CVS is cheaper: CVS trades at a 44.92 P/E and ISRG at 49.83.

Which has grown faster, CVS or ISRG?

Over the past five years, ISRG grew revenue faster — CVS at a 8.52% CAGR versus ISRG at 18.39%.

Does CVS or ISRG pay a bigger dividend?

CVS pays a dividend (2.61% yield) while ISRG does not currently pay one.

Is CVS or ISRG more profitable?

ISRG runs the higher net margin — CVS at 0.72% versus ISRG at 28.15%.

Which has been the better investment, CVS or ISRG?

Over the past 10-year, ISRG delivered the higher annualized total return — CVS at 3.66% versus ISRG at 19.14%. Past performance doesn't predict future results.

CVS Health Corporation (CVS) vs Intuitive Surgical, Inc. (ISRG)

ISRG leads on 9 of 15 compared metrics, though CVS is the cheaper stock.

A side-by-side comparison of CVS Health Corporation and Intuitive Surgical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CVS

CVS Health Corporation

$130.09B

$101.96Healthcare

ISRG

Intuitive Surgical, Inc.

$145.58B

$411.06Healthcare

Total return — CVS vs ISRG

growth of $100 · last 26y

CVS +431.3%ISRG +20149.3%ISRG compounded faster

Log scale — wide-divergence pair

CVS ISRG

CVS vs ISRG: by the numbers

•ISRG is the larger company ($145.58B vs $130.09B market cap).
•CVS trades at the lower earnings multiple (44.92 vs 49.83 P/E).
•ISRG converts more revenue to profit (28.15% vs 0.72% net margin).
•ISRG grew revenue faster over the past five years (18.39% vs 8.52% CAGR).
•CVS pays a dividend (2.61% yield) while ISRG does not currently pay one.

Which is better, CVS or ISRG?

Metric tally: CVS 6 · ISRG 9

It depends on what you're optimizing for:

ValueCVS(lower P/E)

GrowthISRG(faster 5Y revenue CAGR)

QualityISRG(higher ROIC)

Valuation

Metric	CVS	ISRG
P/E ratio	44.92●	49.83
Forward P/E	12.17●	34.90
P/S ratio	0.32●	13.98
P/B ratio	1.68●	8.46
PEG ratio	—	3.17
EV / EBITDA	17.90●	35.41
FCF yield	5.67%●	1.92%

Profitability

Metric	CVS	ISRG
Gross margin	13.87%	66.29%●
Operating margin	1.46%	30.45%●
Net margin	0.72%	28.15%●
ROE	3.79%	17.05%●
ROIC	4.72%	13.71%●

Dividends

Metric	CVS	ISRG
Dividend yield	2.61%	—
Payout ratio	190.00%	—

Growth (annualized)

Metric	CVS	ISRG
Revenue CAGR (5Y)	8.52%	18.39%●
EPS CAGR (5Y)	-23.89%	21.51%●
FCF CAGR (5Y)	-10.57%	16.61%●
Total return CAGR (5Y)	7.06%	7.37%●

Frequently asked

Which is better, CVS or ISRG?: It depends on your goal. value: CVS (lower P/E); growth: ISRG (faster 5Y revenue CAGR); quality: ISRG (higher ROIC). Across all compared metrics, ISRG leads 9 to 6.
Is CVS or ISRG cheaper?: On trailing earnings, CVS is cheaper: CVS trades at a 44.92 P/E and ISRG at 49.83.
Which has grown faster, CVS or ISRG?: Over the past five years, ISRG grew revenue faster — CVS at a 8.52% CAGR versus ISRG at 18.39%.
Does CVS or ISRG pay a bigger dividend?: CVS pays a dividend (2.61% yield) while ISRG does not currently pay one.
Is CVS or ISRG more profitable?: ISRG runs the higher net margin — CVS at 0.72% versus ISRG at 28.15%.
Which has been the better investment, CVS or ISRG?: Over the past 10-year, ISRG delivered the higher annualized total return — CVS at 3.66% versus ISRG at 19.14%. Past performance doesn't predict future results.

Go deeper

Full CVS analysis Full ISRG analysis Interactive comparison tool

Dig into the metrics

CVS Health P/E ratio Intuitive Surgical P/E ratio CVS Health dividend yield Intuitive Surgical dividend yield CVS Health ROE Intuitive Surgical ROE CVS Health operating margin Intuitive Surgical operating margin CVS Health revenue growth Intuitive Surgical revenue growth CVS Health free cash flow Intuitive Surgical free cash flow

CVS Health & Intuitive Surgical appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.